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 27 
ABSTRACT 28 
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus. It has a positive sense RNA 29 
genome that also serves as the mRNA for four non-structural proteins (nsPs) representing 30 
subunits of the viral replicase. Coupling of nsP and RNA synthesis complicates analysis of 31 
viral RNA replication. We developed trans-replication systems, where production of 32 
replication competent RNA and expression of viral replicase are uncoupled. Mammalian and 33 
mosquito RNA polymerase I promoters were used to produce non-capped RNA templates, 34 
which are poorly translated relative to CHIKV replicase generated capped RNAs. It was 35 
found that, in human cells, constructs driven by RNA polymerase I promoters of human and 36 
Chinese hamster origin performed equally well. In contrast, RNA polymerase I promoters 37 
from Aedes mosquitoes exhibited strong species specificity. In both mammalian and mosquito 38 
cells, novel trans-replicase assays had exceptional sensitivity, with up to 10
5
-fold higher 39 
reporter expression in the presence of replicase relative to background. Using this highly 40 
sensitive assay to analyse CHIKV nsP1 functionality, several mutations that severely reduced, 41 
but did not completely block, CHIKV replicase activity were identified: (i) tagging the N-42 
terminus of nsP1 with eGFP; (ii) mutations D63A and Y248A blocking the RNA capping; 43 
(iii) mutation R252E affecting nsP1 membrane anchoring. In contrast, a mutation in the nsP1 44 
palmitoylation site completely inactivated CHIKV replicase in both human and mosquito 45 
cells and was lethal for the virus. Our data confirms that this novel system provides a valuable 46 
tool to study CHIKV replicase, RNA replication and virus-host interactions.  47 
  48 
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IMPORTANCE 49 
Chikungunya virus (CHIKV) is a medically important pathogen responsible for recent large-50 
scale epidemics. The development of efficient therapies against CHIKV has been hampered 51 
by gaps in our understanding of how non-structural proteins (nsPs) function to form the viral 52 
replicase and replicate virus RNA. Here we describe an extremely sensitive assay to analyse 53 
the effects of mutations on virus RNA synthesis machinery in both cells of mammalian (host) 54 
and mosquito (vector) origin. Using this system several lethal mutations in CHIKV nsP1 were 55 
shown to reduce but not completely block the ability of its replicase to synthesize viral RNAs. 56 
However, in contrast to related alphaviruses, CHIKV replicase was completely inactivated by 57 
mutations preventing palmitoylation of nsP1. These data can be used to develop novel, virus-58 
specific antiviral treatments.   59 
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INTRODUCTION 60 
Genome replication of RNA viruses is carried out by an RNA-dependent-RNA polymerase 61 
complex (replicase) that consists of one or more virus-encoded proteins and may also 62 
incorporate host-cell proteins. For positive-strand RNA viruses the virus-encoded 63 
component(s) of replicase are directly translated from the RNA genome. Its expression 64 
depends on RNA replication and vice versa; RNA replication depends on expression and 65 
functional activity of viral replicase. Thus, for these viruses RNA synthesis and replicase 66 
expression are functionally coupled.  67 
Alphaviruses (family Togaviridae) comprise a group of positive-strand RNA viruses that 68 
includes important human pathogens such as Chikungunya virus (CHIKV) as well as several 69 
well-studied model viruses including Semliki Forest virus (SFV) and Sindbis virus (SINV). 70 
Most alphaviruses are mosquito-vectored (1) and can efficiently replicate in cells of vertebrate 71 
and arthropod origin. Alphavirus infection in vertebrate cells is highly cytotoxic. In contrast, 72 
infection of arthropod cells is non-cytotoxic and results in a persistent low-level infection. 73 
Alphaviruses have RNA genomes that are approximately 12 kb in size with a 5’ cap and 3’ 74 
poly(A) tail. The genome consists of two open reading frames (ORFs). The 3’ ORF encodes 75 
for a structural polyprotein which is translated from a subgenomic (SG) RNA transcribed 76 
under the control of a SG promoter in infected cells (2). The virus-encoded replicase subunits, 77 
termed non-structural proteins (nsPs), are expressed in the form of a non-structural (ns) 78 
polyprotein precursor(s) (P123 and P1234) from the ORF located at the 5’ two-thirds of the 79 
virus genome (3). The ns-polyprotein is proteolytically processed by nsP2 which has protease 80 
activity (4) initially resulting in a short-lived negative-strand RNA polymerase (P123 + nsP4) 81 
that is subsequently converted into a stable positive-strand RNA polymerase 82 
(nsP1+nsP2+nsP3+nsP4) (5). All four nsPs as well as most of their processing intermediates 83 
(P1234, P123 and P23) are strictly required for alphavirus RNA replication (3). 84 
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Replicative functions of alphavirus replicase proteins are relatively well-studied. nsP1 is a 85 
virus-specific methyl- and guanylyltransferase and serves as membrane anchor for virus 86 
replicase (6, 7). nsP2 is a papain-like cysteine protease (8), NTPase (9), RNA triphosphatase 87 
(10) and RNA helicase (11). NsP3 of Old World alphaviruses binds cellular G3BP proteins 88 
that are required for RNA replication (12). It also contains an N-terminal macro-domain with 89 
the ability to bind ADP-ribose and remove it from mono ADP-ribosylated substrates. This is 90 
crucial for viral RNA replication (13). nsP4 is the catalytic subunit of viral RNA polymerase 91 
(14, 15) and also has terminal adenylyltransferase activity (16). In addition, all of these 92 
proteins have a number of essential functions that are not directly linked to viral RNA 93 
replication. Thus, nsP1 has been reported to antagonize an anti-viral protein, tetherin (17), 94 
nsP2 of Old World alphaviruses triggers degradation of host cell RNA polymerase II (18) and 95 
antagonizes type-I interferon signalling (19), nsP3 modulates the phosphatidylinositol-3-96 
kinase (PI3K)-Akt-mammalian target of rapamycin (mTOR) pathway (20) and is responsible 97 
for translational shutoff in infected cells (21). nsP4 is involved in suppression of the unfolded 98 
protein response (22). While enzymatic functions of nsPs are well conserved for all 99 
alphaviruses their non-replicative functions exhibit a significant variation depending on virus 100 
and its host. For example nsP2 is cytotoxic only in the case of Old World alphaviruses (23) 101 
and only in vertebrate cells (18). The multiple functions of nsPs, their variation between 102 
different alphaviruses and the coupled nature of nsP expression and viral RNA replication 103 
complicates the analysis of functional significance of nsPs, their different mutations as well as 104 
investigating the role of host cell interaction partners in alphavirus RNA replication. 105 
De-coupling the viral replicase protein(s) expression from viral RNA synthesis represents a 106 
powerful approach to study viral RNA replication. This has been proven useful to study the 107 
replication of influenza virus (24, 25), flavivirus Kunjin virus (26) and nodavirus flock house 108 
virus (27). In addition, the ability of viral replicase to amplify RNA template provided in 109 
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trans has also allowed construction of yeast-based replication systems for bromo-, noda- and 110 
tombusviruses (28–30). In the case of alphaviruses, de-coupled replication systems are 111 
generally designed to amplify truncated RNA templates where the ns- and structural ORFs of 112 
alphavirus genome are replaced by sequences encoding for different reporter proteins; such 113 
systems are often referred to as trans-replication systems. Trans-replication systems have been 114 
developed for SINV, SFV and CHIKV and used to study alphavirus replication complex 115 
biogenesis (31–33), RNA template sequence requirements (34), analysis of the impact of 116 
template length on the size of replication complexes (35), tagging of different replicase 117 
proteins (36) and analysis of the impact of different mutations introduced into replicase 118 
proteins on viral RNA replication in mammalian (8, 37, 38) and mosquito cells (39). While 119 
these studies have universally found the alphavirus trans-replication systems to be efficient 120 
and robust tools they have also revealed certain technical limitations. Namely, to produce 121 
replication competent template RNA and mRNA for expression of replicase polyproteins, 122 
alphavirus trans-replication systems have traditionally used either bacteriophage T7 RNA 123 
polymerase and corresponding promoters (33) or cellular RNA polymerase II promoters such 124 
as the immediate early promoter of human cytomegalovirus (CMV) or Aedes aegypti 125 
polyubiquitin promoter (Ubi) (36, 39). The major drawback of the use of bacteriophage T7 126 
RNA polymerase promoters is that use of such trans-replication systems is restricted to cell 127 
lines expressing T7 RNA polymerase, which are generally not available for cell types relevant 128 
for in vivo alphavirus infections. The use of promoters for cellular RNA polymerase II allows 129 
the use of a wider range of cell types. However, such systems suffer from reduced sensitivity, 130 
especially with regards to replicase-mediated amplification of reporter activity used to replace 131 
the ns-ORF of virus genome and thus expressed from full-length RNA template. The effect is 132 
due to high background activity of reporter resulting from its efficient translation using RNA 133 
polymerase II generated capped transcripts. This activity is often comparable or even higher 134 
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than reporter activity produced from much more abundant viral replicase generated full-length 135 
positive-strand RNAs (36, 39).  136 
In this study several approaches were applied to overcome the above-mentioned limitations of 137 
alphavirus trans-replicase systems. It was found that inserting the sequence, corresponding to 138 
the 5’ end of the CHIKV genome, directly at the start site of human, Chinese hamster, Aedes 139 
aegypti or Aedes albopictus RNA polymerase I promoter allowed production of replication-140 
competent transcripts. These RNAs are, presumably due to the lack of 5’ cap-structure, poorly 141 
translated resulting in significantly reduced background levels of included reporters and 142 
enhanced sensitivity of the trans-replication assay. The template constructs with human or 143 
Chinese hamster RNA polymerase I promoters were active in various primate cell lines. 144 
Higher species specificity was observed for template constructs harboring either Aedes 145 
aegypti or Aedes albopictus RNA polymerase I promoter.  146 
The increased sensitivity of the system was used to re-evaluate 13 mutant versions of CHIKV 147 
replicase previously reported to be inactive or to have activities close to background level. A 148 
set of mutations in CHIKV nsP1, including both mutations in methyl- and guanylyltransferase 149 
active site and mutations affecting membrane anchoring of nsP1, were also analyzed using 150 
CHIKV trans-replicase and infectious clone systems. Highly consistent results confirmed 151 
some findings previously reported for SFV; however, it was also found that, unlike SFV, 152 
mutation of the palmitoylation site of nsP1 in CHIKV is lethal in the context of viral genome 153 
and completely abolishes its replicase activity. These findings confirm the improved trans-154 
replication system as an extremely sensitive and robust system to study alphavirus RNA 155 
replication. 156 
  157 
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RESULTS  158 
Trans-replicases of alphaviruses allow analysis of synthesis of full-length negative- and 159 
positive-strand copies of suitable template RNAs as well as SG RNAs transcribed from SG 160 
promoter(s) included into template RNA. However, directly analysing such RNAs using 161 
northern blotting and/or strand-specific RT-qPCR is time- and resource consuming and not 162 
convenient for large scale experiments such as screening libraries of antiviral compounds. 163 
Incorporation of one or more reporter coding sequences into template RNA constructs allows 164 
the use of the much more convenient measurement of reporter activities as proxy for synthesis 165 
of corresponding positive-strand RNAs, and is also applicable in high-throughput format. 166 
Therefore in the current study, as previously (8, 36, 39), firefly luciferase (Fluc) was used to 167 
substitute most of the ns-ORF and Gaussia luciferase (Gluc) to substitute the structural ORF 168 
in template constructs (Fig. 1B, 2B). For simplicity, hereafter the full-length RNA serving as 169 
template for Fluc translation is termed “genomic RNA” (and its synthesis as “replication”), 170 
RNA synthesized from the SG promoter that serves as template for Gluc translation is termed 171 
“SG RNA” (and its synthesis as “transcription”) and all RNAs synthesized by CHIKV trans-172 
replicase are referred to as “viral RNAs”.  173 
It has been observed that alphavirus trans-replication systems, where initial template RNA 174 
subsequently used by virus replicase is produced by cellular RNA polymerase II, can be 175 
efficiently used for analysis of transcription but not of RNA replication (36, 39). The intrinsic 176 
problem is that although large amounts of genomic RNAs are synthesized from such 177 
templates by viral replicase (36) the activity of Fluc reporter from such RNAs is masked by 178 
high background levels originating from the efficient translation of smaller amounts of initial 179 
capped template RNA transcripts. Therefore, the increase of Fluc activity is only observed for 180 
replicase mutants that boost viral RNA synthesis to levels considerably exceeding these 181 
achieved by wild type (wt) replicase (39). Even the amplification of signal for Gluc, that in 182 
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commonly used cell lines is typically more than 1000-fold for wt replicase (36), can be 183 
insufficient for the analysis of mutant replicases with severely reduced RNA synthesis 184 
activity. Therefore systems with higher sensitivity and with more prominent boost of Gluc 185 
and especially Fluc activities are required.  186 
Design of plasmids for production of non-capped template RNAs. It has been observed 187 
that use of inefficiently translated template RNA transcripts synthesized by RNA polymerase 188 
of bacteriophage T7 increased the sensitivity of a trans-replication system (36). Importantly, 189 
these data also indicate that replicases of alphaviruses are capable of binding to and initiating 190 
the replication of template RNAs lacking a 5’ cap structure. This property was used in four 191 
new templates designed for use in mammalian cells. In CMV-HH-Fluc-Gluc template the 192 
leader sequence corresponding to residues 1-137 of tobacco mosaic virus (TMV) including 193 
first 23 codons of its replicase followed by three terminator codons and a hammer head 194 
ribozyme (HH RZ) was inserted between the start site of CMV promoter and a nucleotide, 195 
corresponding to the 5’ end of CHIKV genome (Fig. 1B), so that the primary capped 196 
transcript has 193 non-viral nucleotides (Table 1) upstream of CHIKV-specific sequence. 197 
Upon ribozyme cleavage, non-capped RNAs with the authentic 5’ end of CHIKV genome and 198 
therefore suitable for use by CHIKV replicase are generated. Similarly, in HSPolI-HH-Fluc-199 
Gluc constructs, a full length promoter for human RNA polymerase I was used to drive the 200 
transcription of initial template RNA while HH RZ was used to generate the authentic 5’ end 201 
(Fig. 1B, Table 1). In addition, two constructs utilizing the design that has been successfully 202 
used to develop reverse genetics systems of negative-strand RNA viruses (40–44) were made. 203 
These constructs are HSPolI-Fluc-Gluc and CGPolI-Fluc-GLuc, using only non-transcribed 204 
parts of RNA polymerase I promoters from human and Chinese hamster, respectively (Fig. 205 
1B, Table 1). 206 
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RNA polymerase I promoters and terminators have been mapped for both principal vectors of 207 
CHIKV, Aedes aegypti (45) and Aedes albopictus (46, 47). Interestingly, in these promoters 208 
the region with highest sequence similarity is located immediately downstream of the 209 
transcription start site of rRNA (45). Three Aedes-specific template RNA expressing 210 
constructs were designed. First, in AegPolI-HH-Fluc-Gluc constructs, the full length upstream 211 
promoter of Aedes aegypti RNA polymerase I and HH RZ were used (Table 1); the construct 212 
also contained the Aedes aegypti RNA polymerase I terminator (Fig. 2B). Next, in the 213 
template construct designated AegPolI-Fluc-Gluc only non-transcribed part of the promoter 214 
was used (Table 1). Finally, in the template construct designated AlbPolI-Fluc-Gluc, the 215 
Aedes aegypti RNA polymerase I promoter and terminator were replaced with their 216 
counterparts from Aedes albopictus (Table 1). Hepatitis delta virus negative strand ribozyme 217 
(HDV RZ) sequence was added to ensure cleavage of all RNA templates immediately 218 
downstream of poly(A) sequence (Fig. 1B, 2B). 219 
Template RNA encoding plasmids utilizing human and Chinese hamster RNA 220 
polymerase I promoters are efficient in primate cells. A panel of constructs consisting of 221 
CMV-Fluc-Gluc and four new templates (CMV-HH-Fluc-Gluc, HSPolI-Fluc-Gluc, HSPolI-222 
HH-Fluc-Gluc and CGPolI-Fluc-Gluc) was analyzed in two primate (U2OS (human), Vero 223 
E6 (African green monkey)) and two rodent (BHK-21 (Syrian golden hamster) and CHO 224 
(Chinese hamster)) cell lines. The Fluc and Gluc activities detected in CHO cells were always 225 
close to the background level suggesting that CHIKV replicase works inefficiently, if at all, in 226 
CHO cells; for this reason these cells were excluded from further analysis. Results obtained 227 
for CMV-Fluc-Gluc template were consistent with these previously observed (36); the 228 
expression of Fluc marker occurred at a high level also in cells co-transfected with CMV-229 
Fluc-Gluc + CMV-P1234
GAA
 – a negative control containing a polymerase-inactivating 230 
mutation in nsP4. The increase of Fluc activity in the presence of active (versus inactive) 231 
 o
n
 July 2, 2019 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
11 
 
replicase was very low (~2 fold) (Fig. 3A). In contrast, strong boost of Gluc activity was 232 
observed in all cell lines, being highest in U2OS and BHK-21 (~20,000-fold) and slightly 233 
lower in Vero E6 cells (~5,000-fold) (Fig. 3A).  234 
Adding a leader and HH RZ to the template reduced Fluc background in control cells less 235 
than 10-fold. The high Fluc activity in the presence of inactive replicase indicates that 236 
additional TMV sequences and HH RZ cleavage were not sufficient to block Fluc translation. 237 
It is likely that CHIKV replicase cannot efficiently use templates with 193 additional residues 238 
upstream of the native 5’ end of the viral genome (Table 1). If so, boosting of expression of 239 
both reporters by active replicase (Fig. 3A) indicates that ribozyme-mediated cleavage did 240 
occur at some level. The low cleavage efficiency/speed apparently led to only low amounts of 241 
templates with correct 5’ ends in cells transfected with CMV-HH-Fluc-Gluc which in turn 242 
resulted in reduced Fluc and especially Gluc activity in the presence of CHIKV-P1234. 243 
Consequently, boost of Fluc expression remained low (Fig. 3A). Compared to those achieved 244 
for CMV-Fluc-Gluc, boosts of Gluc activities for CMV-HH-Fluc-Gluc were significantly 245 
lower in all three cell lines, typically less than 1,000-fold (Fig. 3A). Taken together, it was 246 
concluded that while used approach was not efficient enough to prevent Fluc translation from 247 
RNA polymerase II generated transcripts HH RZ was capable to generate at least some 248 
amount of initial transcripts with proper 5’ ends that were subsequently utilized by CHIKV 249 
replicase.  250 
Use of RNA polymerse I promoters greatly improved system performance. Although the 251 
absolute levels of Fluc and Gluc activities observed in cells transfected with HSPolI-Fluc-252 
Gluc + CMV-P1234 or CMV-Fluc-Gluc + CMV-P1234 were similar in U2OS cells, the much 253 
lower background activity of both reporters expressed by HSPolI-Fluc-Gluc made the assay 254 
using the latter template generally much more sensitive. First and most importantly, the boost 255 
of Fluc activity was significantly increased in all cell lines used, being highest (>2,000-fold) 256 
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in U2OS cells (Fig. 3A). Second, the boost of Gluc activity also significantly increased in 257 
U2OS cells where it exceeded 100,000-fold; the effect was less pronounced but still 258 
significant in Vero E6 cells. In contrast, in BHK-21 cells CMV-Fluc-Gluc reached higher 259 
boost levels of Gluc expression compared to HSPolI-Fluc-Gluc (Fig. 3A). As CHIKV 260 
replicates well in both Vero E6 and BHK-21 cells the observed trend most likely reflects a 261 
reduced activity of human RNA polymerase I promoter in monkey and especially in rodent 262 
cells relative to the human-derived U2OS cells. The effect of incorporating HH RZ was 263 
consistent with the observation above - expression of reporters in cells transfected with 264 
HSPolI-HH-Fluc-Gluc template was reduced which resulted in significantly diminished boost 265 
efficiencies of both markers in primate cells (Fig. 3A). Only in BHK-21 cells, boost of Gluc 266 
activity achieved through the use of HSPolI-HH-Fluc-Gluc was similar to that achieved using 267 
HSPolI-Fluc-Gluc and the boost of Fluc activity was even more prominent (Fig. 3A). Most 268 
likely, the presence of the downstream region of human RNA polymerase I promoter allowed 269 
it to be used more efficiently in rodent cells. 270 
Finally, construct CGPolI-Fluc-Gluc was tested in all three cell lines. Surprisingly, the 271 
construct performed poorly (~8-fold boost of Fluc and ~380-fold boost of Gluc activities) in 272 
BHK-21 cells. In contrast, it was highly active in U2OS and Vero E6 cells showing boosts 273 
comparable to these observed for HSPolI-Fluc-Gluc construct suggesting this rodent RNA 274 
polymerase I promoter is highly active in primate cells (Fig. 3A). Taken together, these 275 
experiments revealed U2OS cells and HSPolI-Fluc-Gluc construct as the most sensitive 276 
combination; therefore it was selected for subsequent experiments.  277 
Measurement of Fluc and Gluc activities is a convenient, but indirect, method for analysis of 278 
CHIKV replicase activity. To demonstrate that Fluc and Gluc activities indeed reflect 279 
synthesis of viral positive-strand RNAs, northern blot analysis was performed using 280 
transfected U2OS and BHK-21 cells. Negative strand synthesis, which is not detectable 281 
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through the measurement of reporter activities (34), was also assessed. Efficient synthesis of 282 
genomic and SG RNAs was observed in U2OS cells co-transfected with CMV-Fluc-Gluc, 283 
HSPolI-Fluc-Gluc or CGPolI-Fluc-Gluc and CMV-P1234. The presence of HH RZ reduced 284 
positive-strand RNA synthesis for both CMV and HSPolI promoter-based vectors; again, 285 
most likely this indicates that the HH RZ is not efficient enough in generating RNAs with 286 
proper 5’ ends. The synthesis of negative-strand RNA was found to follow the same pattern 287 
(Fig. 3B, left panels). In BHK-21 cells, strong replication/transcription was observed only for 288 
CMV-Fluc-Gluc derived template RNAs. The replication of template RNA generated from 289 
CMV-HH-Fluc-Gluc was diminished and no replication products could be detected in cells 290 
transfected with CMV-P1234 and HSPolI-Fluc-Gluc, HSPolI-HH-Fluc-Gluc or CGPolI-Fluc-291 
Gluc (Fig. 3B, right panels). Taken together these results demonstrated an excellent 292 
correlation between levels of replicase generated RNAs and expression of reporters translated 293 
from viral positive-strand RNAs. 294 
 295 
Template RNA encoding plasmids utilizing RNA polymerase I promoters from Aedes 296 
mosquitoes display species specificity. A panel consisting of Ubi-Fluc-Gluc and three new 297 
constructs (AegPolI-HH-Fluc-Gluc, AegPolI-Fluc-Gluc and AlbPolI-Fluc-Gluc) was 298 
analyzed in Aedes albopictus derived C6/36 cells and Aedes aegypti derived AF319 cells. As 299 
previously observed (39), background activity of Fluc reporter in cells transfected with Ubi-300 
Fluc-Gluc limited the boost of its expression by active CHIKV replicase; only ~3-fold or ~6-301 
fold increase of Fluc activity was observed in C6/36 and AF319 cells, respectively (Fig. 4A). 302 
In contrast, boost of Gluc activity was ~800-fold in C6/36 and ~9,000-fold in AF319 cells 303 
(Fig. 4A).  304 
Both AegPolI-HH-Fluc-Gluc and AegPolI-Fluc-Gluc constructs were highly active in AF319 305 
cells. Again, the use of RNA polymerase I promoter reduced background levels of both 306 
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reporters and, subsequently, increased the boost of both markers: highly increased (~100-fold) 307 
boost of Fluc activity and more slightly, but still significantly, increased (~20,000-fold) boost 308 
of Gluc activity were observed (Fig. 4A). In contrast to human cells where the construct 309 
lacking hammer head ribozyme significantly outperformed the HH RZ version (Fig. 3A) no 310 
significant difference between AegPolI-HH-Fluc-Gluc and AegPolI-Fluc-Gluc was observed 311 
in AF319 cells (Fig. 4A). This may indicate that in Aedes aegypti cells the presence of the 312 
downstream region of RNA polymerase I promoter has bigger impact on the activity of the 313 
RNA polymerase I promoter and thus compensates for the inefficient generation of initial 314 
transcripts with authentic 5’ ends by HH RZ cleavage. Alternatively, or in addition, it may 315 
indicate more efficient cleavage of primary transcripts by HH RZ, as lower temperature (28 316 
o
C instead of 37 
o
C) may facilitate the formation of the ribozyme structure.  317 
AlbPolI-Fluc-Gluc was also highly active and revealed little cell specificity: Fluc and Gluc 318 
boosts in homologous mosquito cells were only slightly higher (Fig. 4A) and the difference 319 
between mosquito cell lines was not statistically significant (p=0.276 for Fluc and p=0.090 for 320 
Gluc). In contrast, AegPolI-Fluc-Gluc was almost completely inactive in C6/36 cells. 321 
Surprisingly, the activity of AegPolI-HH-Fluc-Gluc in C6/36 cells was rather similar to that 322 
of Ubi-Fluc-Gluc (Fig. 4A). These data indicate that the upstream part of RNA polymerase I 323 
promoter of Aedes aegypti is not sufficient to drive transcription in Aedes albopictus cells. 324 
However, the presence of highly conserved sequences located downstream of the transcription 325 
start site (45) compensates for this defect. Taken together, it was found that the most efficient 326 
template/mosquito cell combination was AegPolI-Fluc-Gluc and AF319 cells; for C6/36 cells 327 
the best performance was observed for AlbPolI-Fluc-Gluc template (Fig. 4A). These 328 
combinations were therefore selected for subsequent experiments. 329 
To confirm that the observed differences in Fluc and Gluc reporter activities indeed reflect 330 
differences in the amount of viral RNAs northern blot analysis was performed. Again, an 331 
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excellent correlation between the amount of replicase generated RNAs and expression levels 332 
of reporter proteins was observed. Thus, in C6/36 cells the highest level of replicase generated 333 
RNAs was observed for Ubi-Fluc-Gluc followed by AlbPolI-Fluc-Gluc derived templates. 334 
Replicase generated RNAs were also clearly detected in C6/36 cells transfected with AegPolI-335 
HH-Fluc-Gluc but not with AegPolI-Fluc-Gluc (Fig. 4B, left panel). In AF319 cells, the 336 
highest RNA levels were observed when AegPolI-Fluc-Gluc or AegPolI-HH-Fluc-Gluc were 337 
used with minimal differences between these two. High levels of replicase generated RNAs 338 
were also detected in cells transfected with Ubi-Fluc-Gluc; in cells transfected with AlbPolI-339 
Fluc-Gluc their levels were much lower (Fig. 4B, right panel). It was also observed that 340 
similar to the reporter activities, the levels of replicase made positive-strand transcripts in 341 
mosquito cells were lower than in mammalian cells; in order to obtain comparable images 5-342 
fold excess of mosquito cell derived RNAs and longer exposure of northern blot was required. 343 
Consistently, we were easily able to detect negative-strand RNAs in mammalian cells (Fig 344 
3B) while in mosquito cells their levels were below the limit of detection of the assay.  345 
 346 
CHIKV infection triggers replication of plasmid-encoded template RNAs. Template RNA 347 
encoding constructs also have the potential to serve as sensors of virus infection in vitro and 348 
in vivo (48). For efficient detection, an advanced sensor must possess high sensitivity (high 349 
on/off ratio) and, in induced (infected) state, expression of reporter(s) at a level suitable for 350 
detection. In CHIKV trans-replicase system both of these requirements are clearly met: 351 
expression of Fluc and Gluc markers occur at high level and the on/off ratios are extremely 352 
high, especially for Gluc (>100,000-fold; Fig. 3A). However, a trans-replication system is 353 
different from natural virus infection. Therefore response of selected reporters to virus was 354 
also analysed. For these experiments, U2OS cells and CMV-Fluc-Gluc or HSPolI-Fluc-Gluc 355 
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templates as well as C6/36 cells and Ubi-Fluc-Gluc or AlbPolI-Fluc-Gluc templates were 356 
used.  357 
Infection of U2OS cells transfected with CMV-Fluc-Gluc resulted in significant, (~10-fold) 358 
decrease of Fluc activity (Fig. 5A, left panel). Most likely this effect was caused by inhibition 359 
of expression of Fluc from capped transcripts produced in the nucleus, either due to shutdown 360 
of their synthesis by RNA polymerase II and/or because of virus-induced translational 361 
shutdown. In contrast, expression of the Gluc marker increased ~350-fold indicating efficient 362 
synthesis of Gluc-expressing SG RNAs by incoming virus replicase (Fig. 5A, left panel). In 363 
U2OS cells transfected with HSPolI-Fluc-Gluc CHIKV infection significantly increased 364 
expression of both markers. Expression of Fluc was boosted ~50-fold. The effect, opposite to 365 
that observed in cells transfected with CMV-Fluc-Gluc, presumable derives from the much 366 
lower background level of Fluc activity in non-infected cells. It is also possible that the RNA 367 
polymerase I is less susceptible to CHIKV infection induced degradation, which might then 368 
contribute to the observed effect.  Boost of Gluc marker was, as expected, even more 369 
prominent (~30,000-fold increase). 370 
Infection of C6/36 cells transfected with Ubi-Fluc-Gluc or AlbPolI-Fluc-Gluc resulted in 371 
minor increase of Fluc activity. Although the effect was statistically significant the increase of 372 
Fluc activity upon infection never exceeded 2-fold. As in mammalian cells the boost of Gluc 373 
activity was more prominent, ~55-fold for both vector types and highly significant (Fig. 5B). 374 
The absolute values of Gluc activity in cells transfected with Ubi-Fluc-Gluc were ~15-fold 375 
higher than these in cells transfected with AlbPolI-Fluc-Gluc (Fig. 5B). This correlates with 376 
the observation that the SG RNA levels in the trans-replication system were also higher when 377 
Ubi-Fluc-Gluc was used as the source of template RNA for CHIKV replicase (Fig 4B, left 378 
panel). It may indicate that in C6/36 cells the polyubiquitin promoter is stronger than the 379 
truncated Aedes albopictus RNA polymerase I promoter. 380 
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 381 
Trans-replication systems utilizing RNA polymerase I can be used to distinguish lethal 382 
mutations from ones having strong negative impact on CHIKV RNA synthesis.  383 
Many of the mutations introduced into the alphavirus ns-proteins tend to reduce the infectivity 384 
of the mutant viruses by 1000- to 10,000-fold (38, 49). For that reason, the sensitivity of the 385 
systems relying on the use of CMV-Fluc-Gluc template in U2OS cells or T7-Fluc-Gluc 386 
template in BSR cells may not be sufficient to distinguish between truly lethal (completely 387 
blocking RNA replication) and strongly attenuating mutations which often allow virus to be 388 
rescued and undergo reversion/pseudoreversion or compensation during subsequent 389 
replication. Based on this consideration we re-evaluated the phenotypes of twelve CHIKV 390 
replicase mutants previously reported to be inactive or possess strongly reduced replicase 391 
activity.  392 
Analysis of mutants harboring eGFP at the C-terminal region of nsP1 confirmed previous 393 
findings. Insertion of eGFP after amino acid residue 516 of nsP1 (P1
E
234-C) was 394 
considerably better tolerated than similar insertions after residues 492, 497 or 525 (P1
E
234-A, 395 
P1
E
234-B and P1
E
234-D, respectively) (Fig. 6A, B). It was also observed that from these 396 
three mutants P1
E
234-D displayed the highest transcription activity in U2OS cells (Fig. 6B). 397 
In contrast, in BSR cells it had the lowest transcription activity (36). Most likely this reflects a 398 
host-cell specific effect of the mutation. Indeed, we have previously observed that in rodent 399 
cells, CHIKV replicase mutations tend to have a more prominent effect on the trans-replicase 400 
activity than in human cells (39). The ability of mutant replicase with eGFP attached to the C-401 
terminus of nsP4 (P1234
E
) to perform low level (activity ~1% from that of wt replicase) 402 
replication and transcription was also confirmed (Fig 6A, B); this is consistent with the 403 
previous observation that virus harboring a similar insertion is viable but rapidly loses the 404 
inserted marker (36). A newly constructed replicase harboring eGFP at N-terminus of nsP1 405 
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displayed Fluc activity of only ~2-fold over background (activity at the presence of CMV-406 
P1234
GAA
), however this difference was statistically significant (p<0.01). The transcription 407 
was better detectable (the boost of Gluc activity ~900-fold over background) and highly 408 
significant (p<0.0001). Thus, addition of eGFP to the N-terminus of nsP1 strongly inhibits, 409 
but does not completely block, the activity of CHIKV replicase. A virus harboring 410 
corresponding insertion might therefore be viable but likely also highly unstable. 411 
Mutation in the active site of capping enzyme (P1
DA
234) allowed both Fluc (Fig. 6A) and 412 
Gluc (Fig. 6B) markers expression to occur at levels significantly above background 413 
(p<0.0001 and p<0.001, respectively) clearly indicating synthesis of CHIKV positive-strand 414 
RNAs. As for this mutant the replicase-made RNAs are presumably non-capped and therefore 415 
poorly translated their relative amounts were probably even higher than could be deduced 416 
from the increase of reporter expression. This finding clearly supports the hypothesis that 417 
synthesis of alphavirus positive-strand RNAs can occur in the absentse of nsP1 capping 418 
activity (37, 39). The effects observed for the mutation in the membrane binding peptide of 419 
nsP1 (P1
WA
234) and for mutations known to reduce cytotoxicity (P12
EK
34, P12
EKPG
34) (Fig 420 
6A, B) were consistent with previous findings (36, 39). 421 
A mutation in the active site of nsP2 helicase/NTPase/triphosphatase (P12
KN
34) was clearly 422 
lethal for CHIKV as no activity above background was displayed (Fig 6A, B). Interestingly, a 423 
similar mutation in the context of SFV has been reported to allow reversions to occur (50). If 424 
so, the effect of this mutation is different among different alphaviruses. As the properties of 425 
P1
DA
234 suggest that RNA capping is not an absolute requirement for RNA synthesis it can 426 
be concluded that it was lack of RNA helicase and/or NTPase activity of nsP2 that blocked 427 
synthesis of CHIKV positive-strand RNAs. No Fluc expression above background was 428 
observed for P12
CA
34, P12
WA
34 and P12
CA+SA
34 that have mutations in active site of nsP2 429 
protease. This is in agreement with our previous findings that CHIKV harboring such 430 
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mutations is not viable (8). All three mutants displayed very weak (~3-fold over background) 431 
but still significant (p-values <0.01; <0.0001 and <0.01 respectively) transcription activities. 432 
It is possible that this small activity may reflect some minor ability of unprocessed P1234 to 433 
perform viral RNA synthesis and/or that the bond between nsP3 and nsP4 in P1234 undergoes 434 
very inefficient spontaneous hydrolysis or cleavage by cellular enzymes. Taken together, the 435 
trans-replication system used here allowed clear separation of lethal replicase mutations from 436 
these that allow virus to be rescued. This conclusion is supported by data obtained using the 437 
RNA polymerase I based trans-replication system for analysis of effects of mutations in the 438 
helicase domain of CHIKV nsP2 (51). Similarly, in difficult to transfect murine neuronal cells 439 
the differences between lethal and viable mutants of nsP3 macro domain were clearly 440 
observed (13). 441 
  442 
Mutations in membrane binding regions of nsP1 have strong negative effect on CHIKV 443 
RNA replication and infectivity. In order to perform detailed analysis of CHIKV nsP1 444 
functions, the D63A mutation was introduced into Ubi-P1234 and into CMV-ICRES1, an 445 
infectious cDNA (icDNA) clone of CHIKV. In addition, three additional mutations were 446 
introduced into CMV-ICRES1, CMV-P1234 and Ubi-P1234. First, Tyr248 was substituted to 447 
Ala (Y248A). This residue is located in the membrane binding peptide region of nsP1 of 448 
alphaviruses and is important for membrane binding of nsP1 (52, 53) and/or for its activity as 449 
a capping enzyme (37, 54). Second, Arg252, located inside the membrane binding peptide, 450 
was substituted to Glu (R252E). Third, Cys residues 417-419, representing the palmitoylation 451 
site of CHIKV nsP1, were substituted with Ala residues (3C3A). All these mutations have 452 
been previously studied in the context of SFV trans-replicase and, with exception of D64A (in 453 
SFV numeration is based on the amino acid residue numbers in its nsP1), also in the context 454 
of SFV icDNA. Briefly, in the SFV trans-replicase system none of the mutants allowed 455 
 o
n
 July 2, 2019 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
20 
 
positive-strand RNA synthesis above background level; however, mutations D64A and 456 
Y249A did allow negative-strand RNA synthesis and spherule formation (37). In the context 457 
of SFV genome 3C3A mutation allowed virus rescue (55) and generation of second-site 458 
adaptive mutations (56) while all three mutations in membrane binding peptide were lethal 459 
(57). As we have already revealed, the phenotypes of SFV
W259A
 and CHIKV
W258A
 are clearly 460 
different (39). It was also very recently reported that mutation of C417-C419 to A417-A419 461 
in the context of CHIKV 181/25 genome results in drastic reduction of the virus RNA levels 462 
in cells transfected with transcripts from a corresponding mutant icDNA (58). However, 463 
authors of this study did not report the presence or absence of infectious virus progeny. 464 
Therefore it was of interest to compare the effects of nsP1 mutations on the rescue and RNA 465 
replication of SFV and CHIKV. 466 
The infectious centre assay (ICA) revealed that only the CMV-ICRES1
DA
 was able to form 467 
plaques; however, its infectivity was ~100,000-fold lower than that of wt CHIKV. The lack of 468 
infectivity for CMV-ICRES1
YA
, CMV-ICRES1
RE
 and CMV-ICRES1
3C3A
 was confirmed by 469 
western blotting that could not reveal the presence of capsid protein in cells transfected with 470 
any of these three plasmids. In contrast, synthesis of capsid protein was observed for 471 
CHIKV
D63A
, consistent with the data on infectious virus rescue (Fig. 7A). Sequencing of the 472 
mutated region in the genome of rescued CHIKV
DA
 revealed, however, that the introduced 473 
mutation had reverted. Nevertheless, this data clearly confirms that the lack of capping 474 
activity did not completely prevent positive-strand RNA synthesis which, in turn, allowed 475 
reversion to take place. As no infectious progeny was found for CMV-ICRES1
3C3A 
it was also 476 
concluded that, in contrast to SFV, the mutation of the nsP1 palmitoylation site is lethal for 477 
CHIKV. 478 
Next, the effects of these mutants were analysed in U2OS cells using HSPolI-Fluc-Gluc 479 
template and CMV-P1234 replicase plasmids. With the exception of nsP1
RE
 all nsP1 proteins 480 
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were found to be expressed at similar levels (Fig. 7B). As R253E mutation has similar effect 481 
on SFV nsP1 (37) it can be hypothesized that nsP1
RE
 fails to bind to membranes and this 482 
results in destabilization of the protein. The CMV-P1
WA
234 was able to boost both Gluc and 483 
Fluc expression (~60,000-fold and ~150-fold respectively). In both cases, the difference in 484 
levels achieved using wt CMV-P1234 was ~5-fold (Fig. 7B). At 39
o
C, however, only ~800-485 
fold boost of Gluc and ~4-fold boost of Fluc expression was observed for CMV-P1
WA
234; a 486 
difference from wt CMV-P1234 >300-fold and highly significant (p<0.0001) for both 487 
replication and transcription markers. Thus, the temperature sensitive phenotype resulting 488 
from W258A mutation, formerly revealed only for transcription (39), is clearly applicable for 489 
replication as well. Consistent with data from ICA and capsid protein expression, no replicase 490 
activity above background level was observed for CMV-P1
3C3A
234 and CMV-P1
RE
234 (Fig. 491 
7B). When the assay was performed at 28
o
C the CMV-P1
3C3A
234 remained completely 492 
inactive. In contrast, at reduced temperature Fluc and Gluc activities were boosted by CMV-493 
P1
RE
234 ~3.3-fold and ~350-fold, respectively, and were both significantly above background 494 
level (p<0.01 for Fluc and p<0.05 for Gluc). Thus, in the context of CHIKV replicase, the 495 
R252E mutation results in a strong temperature sensitive phenotype. The substitution 496 
introduced to CMV-ICRES
RE
 (CGC codon to GAG) requires two nucleotide substitutions for 497 
pseudoreversion (GAG to CGG or AGG Arg codons). Based on our experience such 498 
mutations do not revert when introduced to alphavirus icDNAs; therefore rescue of CMV-499 
ICRES1
RE
 at a permissive temperature (28 
o
C) was not attempted. CMV-P1
DA
234 was, again, 500 
able to boost expression of both Fluc and Gluc (Fig. 7A) indicating the presence of sufficient 501 
replicase activity for virus rescue to occur. These activities were, apparently, reduced too 502 
strongly (compared to wt CMV-P1234 ~130-fold for replication and ~230-fold for 503 
transcription) to allow preservation of introduced mutation that could be reverted by change 504 
of a single nucleotide residue (GCT for Ala to GAT for Asp). CMV-P1
Y248A
234 displayed 505 
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even stronger attenuation yet both Fluc and Gluc activities were clearly and significantly 506 
(p<0.05) above background levels (Fig. 7B). The failure to rescue CMV-ICRES1
YA
 (Fig. 7A) 507 
is most likely due to the nature of the introduced substitution (TAC codon to GCC) as two 508 
nucleotide substitutions are required for reversion. Taken together, in U2OS cells only 509 
palmitoylation site mutation resulted in replicase that was completely inactive in all 510 
conditions used. D63A, Y248A and R252E substitutions all displayed some, albeit strongly 511 
reduced, replicase activity at least at some of the tested conditions.  512 
Finally, the same set of mutations was analysed in Aedes aegypti-derived AF319 cells using 513 
AegPolI-Fluc-Gluc template and Ubi-P1234 replicase plasmids. As in mammalian cells, all 514 
nsP1 proteins except nsP1
RE
 were found to be expressed at similar levels (Fig 7C). Again, 515 
only the W258A mutant generated a replication signal similar to that of wt. This data does 516 
not, however, exclude synthesis of positive-strand genomic RNAs by the D63A mutant (and 517 
possibly Y248A mutant) as for this mutant the non-capped replicase-made RNAs would not 518 
have a translation advantage over the initial RNA polymerase I made transcripts. Indeed, the 519 
analysis of transcription signal, which offers higher sensitivity, revealed Gluc activities, 520 
significantly above background for D63A (p<0.05) and Y248A (p<0.05) mutants indicating 521 
synthesis and translation of SG RNAs (Fig. 7C). The Ubi-P1
RE
234 also displayed ability to 522 
increase Gluc levels; however, at this case boost was minor (~3.3-fold) and not statistically 523 
significant (p=0.167). Finally, no replication or transcription was detected for replicase 524 
encoded by Ubi-P1
3C3A
234. The correlation of data from mammalian and mosquito cells 525 
indicates that defects caused by nsP1 mutations were not host cell specific. Our data also 526 
confirmed that the phenotypes caused by the D63A and Y248A mutations in CHIKV and 527 
their counterparts in SFV are similar. This might also be the case for R252E mutation, but the 528 
tools used to study it in the context of SFV had inadequate sensitivity. In contrast, the 529 
phenotype caused by 3C3A mutation in the context of SFV and CHIKV was clearly different: 530 
 o
n
 July 2, 2019 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
23 
 
in the former it must allow replicase activity necessary for virus rescue while in the latter no 531 
evidence of RNA replication could be revealed by any of the highly sensitive assays.  532 
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DISCUSSION. 533 
Use of promoters and terminators of cellular RNA polymerase I resulted in a replicase system 534 
of unprecedented sensitivity. The increased sensitivity was mostly due to the fact that 535 
background level of reporter expression was considerably reduced with little (mosquito cells) 536 
or no (mammalian cells) loss of marker expression at the presence of viral replicase. 537 
Similarly, it may also be advantageous that transcripts made by RNA polymerase I do not 538 
undergo splicing. This may be important for sequences derived from the genomes of positive-539 
strand RNA viruses that often contain cryptic splicing signals. Use of an RNA polymerase I 540 
based system may also improve stability of RNA transcripts. RNAs made from alphavirus 541 
template constructs (Fig. 1B, 2B) have a bicistronic structure. If made by RNA polymerase II 542 
these RNAs behave as mRNAs with abnormally long 3’ UTR that contains non-translated 543 
Gluc ORF and may therefore be recognized by cellular mRNA degradation machinery. 544 
Finally, compared to promoters of RNA polymerase II the RNA polymerase I promoter, that 545 
is normally used for synthesis of ribosomal RNAs, is less likely to have strongly differential 546 
expression or silencing in different tissues. 547 
A caveat for the construction of efficient RNA polymerase I mediated template-RNA 548 
expression constructs is species-specificity, which was observed for both mammalian (Fig. 3) 549 
and Aedes mosquito (Fig. 4) derived promoters. Interestingly, no clear correlation between 550 
promoter origin and the efficiency of the corresponding system in cells from different 551 
organisms was observed. Thus, a human RNA polymerase I promoter had no obvious 552 
advantage over that of Chinese hamster in primate cells (Fig. 3) and was also found to work in 553 
murine cells (13). In contrast, none of these promoters worked efficiently in BHK-21 cells. 554 
The reasons for this remained unknown though it can be speculated that the RNA polymerase 555 
I of Syrian golden hamster cannot recognize the promoter fragments used. This species 556 
specificity represents a significant problem for design of template-RNA expressing constructs 557 
 o
n
 July 2, 2019 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
25 
 
for non-model species where the RNA polymerase I promoters/terminators are not well 558 
characterized. Given the low conservation of the sequences of these elements an analysis of 559 
RNA polymerase I based transcription of these organisms may be required before efficient 560 
template-RNA producing constructs can be designed. An obvious way to alleviate at least 561 
some of these problems would be the use of ribozymes to trim the 5’ and 3’ ends of RNA 562 
transcripts. In this regard it should be noticed that while we experienced no difficulties with 563 
trimming of the 3’ ends of transcripts with an HDV RZ, the use of HH RZ to generate 564 
authentic 5’ ends essentially failed in mammalian cells. However, it worked reasonably well 565 
in the case of mosquito cells alleviating problems related to the observed species specificity 566 
(Fig. 4). Therefore, it can be considered as a potential approach for species where the 567 
information about RNA polymerase I promoter sequence and function is limited or absent. 568 
Consistent with our previous findings (36) relatively little transcript was generated from 569 
CMV-Fluc-Gluc by RNA polymerase II and these RNAs were poorly detectable by northern 570 
blot analysis (Fig.3B). This was also the case for Ubi-Fluc-Gluc transcripts in mosquito cells 571 
(Fig. 4B). In contrast, genomic RNAs synthesized by wt CHIKV replicase were abundant 572 
(Fig. 3B, 4B). However, the increase of RNA copy number resulted in disproportionate boost 573 
of Fluc expression (Fig. 3A, 4A). Most likely this lack of correlation between RNA and Fluc 574 
reporter levels is a consequence of a basic property of alphavirus infection: ns-proteins are 575 
synthesized only at the early stages of infection while the synthesis of their mRNAs (virus 576 
genomes) remains active until cell death (59). Hence, only a small amount of RNA genomes 577 
are used as mRNAs and in the late infection the ratio of ns-proteins to RNA genomes drops 578 
dramatically. Our trans-replication system appears to capture this important property of 579 
alphavirus infection, but this effect limits the use of genomic (Fluc) reporter activity for the 580 
analysis of genomic RNA synthesis. For the RNA polymerase II based system the nucleus-581 
made capped RNA transcripts are the first and most efficiently translated mRNAs for Fluc. 582 
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The increase in replicase-generated genomic RNAs, observed by northern blotting, occurs at a 583 
later stage when they are poorly translated, if at all. Therefore in the RNA polymerase II 584 
based system, translation of genomic reporter (Fluc) from initial transcripts can mask that 585 
from replicase-generated RNAs. Use of non-capped transcripts made by RNA polymerase I 586 
avoids this effect. 587 
It was also observed that in contrast to replication in mammalian cells, replication in mosquito 588 
cells resulted in abnormally high SG to genomic RNA ratio (Fig. 3B and 4B). This may relate 589 
to the use of a truncated 3’ UTR in the template RNAs. The native 3’ UTR of CHIKV 590 
LR2006OPY1 strain comprises 498 nucleotide residues. In contrast, template RNAs used in 591 
this study contain only the last 110 nucleotides (36). The missing part of CHIKV 3’ UTR 592 
contains repeated sequence motifs which have only a minimal effect on CHIKV replication in 593 
mammalian cells (60). In contrast, however, a deletion of this region caused a prominent 594 
reduction of CHIKV replication in both Aedes aegypti and Aedes albopictus cells (61). To the 595 
best of our knowledge, the molecular basis of this defect has not been reported. Thus, it is 596 
plausible that the defect may include a shift of SG to genomic RNA ratio into the favor of the 597 
former. This shift might reflected an altered ratio of synthesis or instability of bicistronic 598 
genomic RNA with truncated 3’ UTR. If so, this trans-replication system may serve as useful 599 
tool for studies on the role of the upstream part of 3’ UTR in RNA synthesis and/or stability. 600 
Such an analysis was, however, outside the scope of current study.  601 
As shown here, alphavirus replicase can use RNA polymerase I generated RNAs as templates; 602 
this emphasizes that the 5’ cap-structure is not required for RNA replication. Even the 603 
ribozyme-generated 5’ ends that lack 5’ phosphate can still be used by alphavirus replicase. 604 
At the same time it is well known that in vitro generated non-capped transcripts from 605 
alphavirus icDNAs are not infectious. Our data indicate that this is most likely a consequence 606 
of low level of replicase proteins synthesis rather than a lack in the ability of the replicase to 607 
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use such transcripts as templates. If so, the role of the cap-structure of viral RNA is to ensure 608 
the correct level of ns-protein expression, stabilize the RNA in the cellular environment (62) 609 
and prevent its recognition by cellular pattern recognition receptors. It has been recently 610 
demonstrated that alphaviruses synthesise non-capped RNAs in normal infection and that 611 
these RNAs are packed into virions (62). Furthermore, it was subsequently shown that an 612 
artificial increase of capping efficiency leads to overproduction of viral nsPs and decrease of 613 
virion formation (63). Authors of these studies did also reveal that virions made in 614 
mammalian cells contain mostly non-capped RNAs while virions made in mosquito cells 615 
contain mostly capped RNAs and have therefore lower particle per PFU ratios (62). These 616 
findings clearly correlate with the behavior of our trans-replication templates. In mammalian 617 
cells, the replicase of an incoming virus was capable to use both capped and non-capped 618 
template RNAs equally well resulting in similar final levels of marker expression (Fig. 5A). 619 
In C6/36 mosquito-derived cells, capped transcripts performed clearly better reaching higher 620 
expression levels (Fig. 5B). This may indicate that in C6/36 cells the non-capped RNAs are 621 
used by viral replicase less efficiently than capped ones. The lack of cap applies, however, 622 
only for the initial replication event as CHIKV replicase facilitates the capping of the RNAs 623 
made by the formed replication complexes; hence thereafter the replication process in the cell 624 
should proceed identically regardless the capping status of initial RNA transcripts. If so, the 625 
lower efficiency of replication (Fig. 5) could indicate that replication is initiated in relatively 626 
few C6/36 cells. A similar phenomenon has previously been observed in C6/36 cells 627 
transfected with a construct expressing SINV template; upon infection with SINV the 628 
replication of the RNA template was evident in only ~5% of the infected cells (48). In line 629 
with these observations we have identified several replicase mutations that boosted replication 630 
of the CHIKV template RNA in mosquito cells between 10-30-fold (39). In contrast, a 631 
mutation in P1234 that is capable of boosting replication of template RNA in mammalian cell 632 
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considerably above the level achieved by wt P1234 has never been identified. All these 633 
findings indicate that initiation of template-RNA replication in mosquito cells by virus-634 
encoded replicase is relatively inefficient. Most likely it is a consequence of the different 635 
environment in mammalian and mosquito cells. The initiation of template RNA replication is 636 
a complex process which includes RNA recognition by virus and host encoded replicase 637 
components, their interaction with host cell membranes, formation and maturation of 638 
replication complexes and so on; analysis of this multi-step process is the topic of on-going 639 
research in our laboratories and different template-RNA expression constucts represent 640 
valuable tools for such studies. 641 
As shown in previous studies, alphavirus trans-replicase is an excellent tool for the analysis of 642 
nsPs functions. Here we took advantage of the increased sensitivity of the RNA polymerase I 643 
based system and analysed the effects of different mutations on the ability of CHIKV nsP1 to 644 
support viral RNA synthesis. The analysis not only confirmed our previous findings that the 645 
C-terminus of nsP1 tolerates insertion of eGFP tag (36) but revealed also that such a tag can 646 
be incorporated into the N-terminus of nsP1. Though the replicase harboring such a tag had 647 
severely diminished activity the finding still clearly demonstrates that N-terminally tagged 648 
nsP1 is a functional protein. It is unclear why an insertion of eGFP to the N-terminus of nsP1 649 
has higher negative impact on its function compared to a similar insertion in the C-terminal 650 
region. It may be a consequence of the N-terminus proximity to important functional motifs 651 
such as the catalytic His residue of guanylyltransferase and the catalytic Asp residue of 652 
methyltransferase, being located only 37 and 63 amino acid residues downstream, 653 
respectively (64). At this point it is not clear whether the similarity of properties of P
E
1234 654 
and P1
DA
234 (Fig. 5) is coincidental or reflects the similar nature of the defect (presumably 655 
lack of RNA capping) caused by these mutations. It was also found that mutations Y248A and 656 
R252E, counterparts of which have been shown to abolish ability of SFV replicase to 657 
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synthesize positive-strand RNAs (37), severely reduced but did not completely blocked 658 
CHIKV replicase activity. In these cases, the observed difference between SFV and CHIKV 659 
could most likely be explained by the more sensitive assay used in this study and the 660 
temperature sensitive nature of the defect(s) caused by R252E mutation. More likely than not, 661 
both of these mutations affect SFV and CHIKV in the same way. In contrast, the effect of 662 
mutation in the palmitoylation site of CHIKV nsP1 was clearly different from that reported in 663 
SFV. No activity of this mutant CHIKV genome or its replicase was evident in our studies 664 
indicating the lethal nature of the mutation. Interestingly, another defect of similar type has 665 
also been described. Inability of nsP3 of SFV to bind cellular G3BP proteins results in 666 
attenuated phenotype (65); in contrast, binding of G3BPs by nsP3 is crucial for CHIKV 667 
replication (12). nsP1 palmitoylation is required for correct interactions of alphavirus 668 
replicase proteins and their association with membranes (56). It has also been suggested that 669 
G3BPs participate in the formation of replicase complexes (12). Therefore it can be 670 
speculated that both of these differences between CHIKV and SFV may have a common 671 
cause.  672 
The replication and transcription of reporter-encoding template RNA has been used for 673 
detection of SINV infection in mosquitoes. In vivo, up to ten-fold activation of reporter 674 
expression upon infection by homologous virus was observed. Interestingly, when the same 675 
experiment was performed using transiently transfected C6/36 cells, the boost of marker 676 
expression was more modest, ~2-fold (48). In a comparable setup, both Ubi-Fluc-Gluc and 677 
AlbPolI-Fluc-Gluc derived template RNAs showed ~55-fold boost of reporter expression 678 
(Fig. 5B) clearly outperforming the previously analysed SINV template construct. Therefore 679 
it is likely that the constructs reported in this study would have superior properties that would 680 
make them suitable for the generation of stable insect cell lines and transgenic mosquitoes. 681 
The same applies, likely to much bigger extent, to mammalian cells and HSPolI-Fluc-Gluc 682 
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template expression construct. In a transient setup, nearly 30,000-fold activation of Gluc 683 
expression was observed upon virus infection (Fig 5A). As the background of the Gluc 684 
expression was negligible and the on/off ratio as good or superior to any reported inducible 685 
expression system to-date, the design may have several potential uses. This includes in vitro 686 
applications such as inducible expression of toxic proteins in cell culture or construction of 687 
cell lines for easy detection and quantification of alphavirus infection. In addition, a potential 688 
in vivo application might be the generation, through transgenesis, of animals carrying such an 689 
inducible reporter. This could in principle be used to monitor and trace virus infection with 690 
unprecedented sensitivity and accuracy.  691 
  692 
 o
n
 July 2, 2019 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
31 
 
MATERIALS AND METHODS 693 
Cells. 694 
All mammalian cell lines were maintained at 37°C in a humidified atmosphere with 5% CO2. 695 
U2OS human bone osteosarcoma cells (ATCC HTB-96) were maintained in Iscove's 696 
modified Dulbecco's medium (Gibco) containing 10% fetal bovine serum (FBS; GE 697 
Healthcare) and 2 mM L-glutamine. Vero E6 African green monkey kidney cells (ATCC 698 
CCL-81) were grown in Dulbecco’s modified Eagle’s medium (Gibco) containing 10% FBS 699 
and 2 mM L-glutamine. BHK-21 baby hamster kidney cells (ATCC CCL-10) were grown in 700 
Glasgow’s minimal essential medium (Gibco) containing 10% FBS, 2% tryptose phosphate 701 
broth (TPB) and 200 mM HEPES pH 7.2. All mosquito-derived cell lines were maintained at 702 
28°C with no additional CO2. Aedes albopictus C6/36 cells were maintained in Leibowitz’s L-703 
15 medium (Corning) containing 10% FBS. Aedes aegypti Aag2 cell-derived Dicer2 knockout 704 
cell line AF319 (66) was maintained in Leibowitz’s L-15 medium (Corning) containing 20% 705 
FBS, 10% TPB and 1X non-essential amino acids. All media were supplemented with 100 706 
U/mL penicillin and 0.1 mg/mL streptomycin. 707 
Construction of plasmids for production of RNA templates in mammalian cells. 708 
CMV-Fluc-Gluc, a vector designed for expression of replication-competent template RNA of 709 
CHIKV using cellular RNA polymerase II in mammalian cells, has been previously described 710 
(36). A 193 bp long sequence, corresponding to 137 5’ residues of TMV including 23 first 711 
codons of its replicase ORF followed by three in-frame stop codons and a HH RZ designed to 712 
cleave RNA transcript immediately upstream of the residue corresponding to the 5’ end of 713 
CHIKV genome, was inserted between the start site of CMV promoter and the beginning of 714 
CHIKV-specific sequence in CMV-Fluc-Gluc using synthetic DNA fragments (Genscript, 715 
USA) and subcloning procedures; the generated plasmid was designated CMV-HH-Fluc-716 
Gluc. Similarly, a synthetic DNA fragment containing sequences corresponding to human 717 
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RNA polymerase I promoter (residues from -211 to +20 with respect to transcription start 718 
site) and HH RZ was used to replace T7 RNA promoter in T7-Fluc-Gluc (36); a 100 bp long 719 
sequence, corresponding to mouse RNA polymerase I terminator, was inserted downstream of 720 
the sequence corresponding to HDV RZ. The generated plasmid was designated HSPolI-HH-721 
Fluc-Gluc. The deletion of sequence corresponding to the downstream region of human RNA 722 
polymerase I promoter (residues +1 to +20) and HH RZ was performed using PCR-based 723 
mutagenesis, the generated plasmid was designated HSPolI-Fluc-Gluc. Finally, the human 724 
RNA polymerase I promoter in HSPolI-Fluc-Gluc was replaced by the corresponding 725 
sequence (positions -227 to -1 with respect to transcription start site) of Chinese hamster 726 
(Cricetulus griseus) resulting in a plasmid designated CGPolI-Fluc-Gluc (Fig. 1B). Sequence 727 
of all plasmids was verified using Sanger sequencing. Sequences from residue -10 of 728 
promoter to residue 10 of CHIKV are shown in Table 1; full sequences are available from 729 
authors upon request.  730 
Construction of plasmids for production of RNA templates in mosquito cells. 731 
Ubi-Fluc-Gluc, a vector designed for the expression of replication-competent template RNA 732 
of CHIKV using cellular RNA polymerase II in mosquito cells, has been previously described 733 
(39). To obtain mosquito RNA polymerase I based constructs, an intron, present in Ubi-Fluc-734 
Gluc, was removed. As the RNA polymerase I promoters of Aedes aegypti and Aedes 735 
albopictus share little similarity (45, 46) separate vectors for template RNA production were 736 
constructed for cells derived from these two mosquito species. To obtain a vector for Aedes 737 
albopictus cells, the polyubiquitin promoter and Simian virus 40 terminators of Ubi-Fluc-738 
Gluc were replaced with Aedes albopictus RNA polymerase I promoter and putative 739 
terminator (100 bp), respectively. A 250 bp promoter fragment (residues -250 to -1) was used, 740 
such that the first nucleotide of the CHIKV genome corresponds to the transcription start. The 741 
generated plasmid was designated AlbPolI-Fluc-Gluc. Similar substitutions were made using 742 
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the RNA polymerase I promoter (residues -250 to -1) and putative terminator (100 bp) of 743 
Aedes aegypti. This resulted in a plasmid designated AegPolI-Fluc-Gluc. Finally, the 744 
sequence corresponding to residues +1 to +50 of RNA polymerase I promoter of Aedes 745 
aegypti followed by the sequence corresponding to a HH RZ, was inserted between start site 746 
of promoter and the residue corresponding to the 5’ end of CHIKV genome in AegPolI-Fluc-747 
Gluc; the resulting plasmid was designated AegPolI-HH-Fluc-Gluc (Fig. 2B). Sequence of all 748 
plasmids was verified using Sanger sequencing. Sequences from residue -10 of promoter to 749 
residue 10 of CHIKV are shown in Table 1; full sequences are available from authors upon 750 
request.  751 
Construction of plasmids for expression of mutant replicase and mutant icDNA 752 
constructs.  753 
Construction of CMV-P1234, CMV-P1234
GAA
, CMV-P1
E
234-A, CMV-P1
E
234-B, CMV-754 
P1
E
234-C, CMV-P1
E
234-D, CMV-P1234
E
, CMV-P12
EK
34, CMV-P12
EKPG
34, CMV-755 
P12
KN
34, CMV-P1
DA
234 and CMV-P1
WA
234 has been previously described (36, 39). In order 756 
to generate constructs designated CMV-P12
CA
34, CMV-P12
WA
34 and CMV-P12
CASA
34 the 757 
region corresponding to mutated nsP2 protease was transferred from T7-P12
CA
34, T7-758 
P12
WA
34 and T7-P12
CA+SA
34 plasmids (8) to the CMV-P1234 plasmid. To fuse eGFP to the 759 
N-terminus of nsP1 a flexible Gly-Gly-Ser-Gly-Gly-Ser linker was added to the C-terminus of 760 
eGFP. Using site-directed PCR mutagenesis and subcloning, a plasmid designated CMV-761 
P
E
1234 was generated. Additional point mutations were incorporated in CMV-P1234 using 762 
site-directed PCR mutagenesis: Y248A (CMV-P1
YA
234), R252E (CMV-P1
RE
234) and 763 
substitution of cysteine residues 417-419 of nsP1 to alanine residues (CMV-P1
3C3A
234). The 764 
latter three mutations as well as D63A substitution were also incorporated into CMV-ICRES1 765 
(also called DREP-ICRES1), an icDNA clone of CHIKV LR2006OPY1 isolate (67) using 766 
site-directed PCR mutagenesis and subcloning procedures. The resulting clones were 767 
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designated CMV-ICRES1
DA
, CMV-ICRES1
YA
, CMV-ICRES1
RE
 and CMV-ICRES1
3C3A
. 768 
Sequence of all plasmids was verified using Sanger sequencing.  769 
Trans-replication assay. 770 
The trans-replication assay was performed as previously described (36). Briefly, U2OS, Vero 771 
E6 and BHK-21 cells grown in 12-well plates were co-transfected with 1 µg of template-772 
expressing vector (CMV-Fluc-Gluc, CMV-HH-Fluc-Gluc, HSPolI-HH-Fluc-Gluc, HSPolI-773 
Fluc-Gluc or CGPolI-Fluc-Gluc) and 1 µg of CMV-P1234 (or its mutant variants) using 774 
Lipofectamine LTX (Thermo Fisher Scientific) reagent according to the manufacturer’s 775 
instructions. Transfected cells were incubated at 37
o
C for 18 h. C6/36 and AF319 cells grown 776 
in 12-well plates were co-transfected with 0.5 µg of template expressing vector (Ubi-Fluc-777 
Gluc, AegPolI-HH-Fluc-Gluc, AegPolI-Fluc-Gluc or AlbPolI-Fluc-Gluc) and 0.5 µg of Ubi-778 
P1234 (or its mutant variants) using Lipofectamine LTX and incubated at 28
o
C for 48 h. After 779 
incubation, cells were lysed and Fluc and Gluc activities were measured using the Dual-780 
Luciferase-Reporter assay on a Glomax SIS luminometer (Promega). All Fluc and Gluc 781 
activities were normalized to these obtained for cells co-transfected with plasmids expressing 782 
corresponding template RNA and CMV-P1234
GAA
 or Ubi-P1234
GAA
 (for mammalian and 783 
mosquito cell experiments, respectively) controls. All assays were repeated at least three 784 
times. 785 
Northern blotting.  786 
U2OS, BHK-21, C6/36 and AF319 cells were co-transfected with plasmids coding for 787 
CHIKV replicase and RNA template as described above. At 18 h (U2OS, BHK-21) or 48 h 788 
(C6/36, AF319) post-transfection total RNA was extracted using TRIzol® reagent (Life 789 
Technologies). Equal amounts of total RNA (for mammalian cells: 2 µg for positive and 10 790 
µg for negative strand analysis; for mosquito cells: 10 µg for positive and 10 µg for negative 791 
strand analysis) were denatured for 10 min at 70°C in 2X RNA loading dye (Thermo 792 
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Scientific), cooled on ice and separated on a denaturing gel (1% agarose/6% formaldehyde) 793 
using 1X MOPS buffer. RNA was transferred to a Hybond-N+ filter (GE Healthcare) and 794 
fixed using a UV Stratalinker 1800 (Stratagene). Digoxigenin (DIG)-labelled RNA probe 795 
complementary to residues 42-390 of the sequence encoding for Gluc marker was used to 796 
detect positive-strand RNAs; probe corresponding to residues 51-376 of the sequence 797 
encoding for Fluc marker was used to detect negative-strand RNAs. Filters were hybridized 798 
overnight; blots were washed and developed according to the manufacturer's (Roche) 799 
protocols. 800 
Activation of template replication by CHIKV infection.  801 
U2OS cells grown in 12-well plates were transfected with CMV-Fluc-Gluc or HSPolII-Fluc-802 
Gluc plasmids. C6/36 cells grown in 12-well plates were transfected with Ubi-Fluc-Gluc or 803 
AlbPolI-Fluc-Gluc plasmids. At 18 h (U2OS) or 36 h (C6/36) post transfection cells were 804 
either infected with CHIKV at an MOI 10 or mock-infected. At 24 h (U2OS) or 72 h (C6/36) 805 
post-infection (h.p.i) cells were collected, lysed and Fluc and Gluc activities were measured 806 
as described above. 807 
Virus rescue and infectious centre assay.   808 
Virus rescue in BHK-21 cells was performed as previously described (68) . ICA was 809 
performed essentially as previously described (49) except that cells were transfected with 5 810 
µg of endotoxin-free plasmids CMV-ICRES1, CMV-ICRES1
DA
, CMV-ICRES1
YA
, CMV-811 
ICRES1
RE
 or CMV-ICRES1
3C3A
. Virus stocks were collected at 24 h (wt CHIKV) or at 48 h 812 
(mutant CHIKV variants) post transfection. Obtained stocks were clarified by centrifugation 813 
at 3000xg for 10 minutes and virus titers were determined using standard plaque assay on 814 
BHK-21 cells.  815 
The transfected cells were collected at the same time as corresponding stocks. Cells were 816 
lysed by boiling in SDS gel-loading buffer (100 mM Tris-HCl pH 6.8, 4% SDS, 20% 817 
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glycerol, 200 mM DTT, and 0.2% bromophenol blue). Lysate corresponding to 50,000 818 
transfected cells was loaded on a 10% polyacrylamide gel. Proteins were separated by SDS-819 
PAGE, transferred to polyvinylidene difluoride membranes, and detected using antibodies 820 
against CHIKV capsid protein (in-house); β-actin (sc-47778; Santa Cruz Biotechnology) was 821 
used as a loading control. The membranes were then incubated with appropriate secondary 822 
antibodies conjugated to fluorescent labels (LI-COR) and proteins were visualized using a LI-823 
COR Odyssey Fc imaging system.  824 
Statistical analysis.  825 
Statistical analysis was done using GraphPad Prism software. Data were analyzed using 826 
Student’s unpaired one tailed t-test. 827 
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FIGURES. 1040 
Figure 1. 1041 
Schematic representation of CMV-P1234 plasmid for CHIKV replicase expression and 1042 
plasmids for expression of RNA templates used in mammalian cells. (A) Expression 1043 
construct for CHIKV ns-proteins. CMV - CMV IE promoter; LI – leader region of herpes 1044 
simplex virus thymidine kinase gene with an artificial intron; SV40Ter - SV40 late 1045 
polyadenylation region. Red arrow highlights the position of the inactivating mutation in the 1046 
nsP4 catalytic site. (B) Constructs expressing template RNAs. CMV* - CMV IE promoter 1047 
followed by TMV-derived leader; HSPolI* – full-length (-211 to +20) promoter for human 1048 
RNA polymerase I; HSPolI – truncated (-211 to -1) promoter for human RNA polymerase I; 1049 
CGPolI – truncated (-227 to -1) promoter for Chinese hamster RNA polymerase I; HH RZ– 1050 
hammer head ribozyme. The 5′ and 3′ UTRs are from CHIKV; N77 - region encoding for the 1051 
77 N-terminal amino acid residues of nsP1; SG - CHIKV SG promoter; HDV RZ - antisense 1052 
strand ribozyme of hepatitis delta virus, MmTer – terminator for RNA polymerase I from 1053 
mouse (Mus musculus). The position of the second intron of the human beta globin gene 1054 
(hBG) in CMV-Fluc-Gluc and CMV-HH-Fluc-Gluc is marked. The vector backbone is not 1055 
shown, drawings are not in scale. 1056 
 1057 
Figure 2. 1058 
Schematic representation of Ubi-P1234 plasmid for CHIKV replicase expression and 1059 
plasmids for expression of RNA templates used in mosquito cells. (A) Expression 1060 
construct for CHIKV ns-polyprotein. Ubi* - full-length Aedes aegypti polyubiquitin 1061 
promoter; UL - transcribed leader of polyubiquitine gene containing naturally occurring 1062 
intron; SV40Ter - SV40 late polyadenylation region. Red arrow highlights the position of the 1063 
inactivating mutation in the nsP4 catalytic site. (B) Constructs expressing template RNAs. 1064 
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Ubi – truncated polyubiquitine promoter; AegPolI* – full-length (-250 to +50) promoter for 1065 
Aedes aegypti RNA polymerase I; AegPolI – truncated (-250 to -1) promoter for Aedes 1066 
aegypti RNA polymerase I; AlbPolI – truncated (-250 to -1) promoter for Aedes albopictus 1067 
RNA polymerase I; HH RZ – hammer head ribozyme; AegTer – tentative terminator for 1068 
Aedes aegypti RNA polymerase I; AlbTer – tentative terminator for Aedes albopictus RNA 1069 
polymerase I. The 5′ and 3′ UTRs are from CHIKV; N77 - region encoding for the 77 N-1070 
terminal amino acid residues of nsP1; SG - CHIKV SG promoter; HDV RZ - antisense strand 1071 
ribozyme of hepatitis delta virus. In Ubi-Fluc-Gluc, the position of the second intron of the 1072 
Drosophila melanogaster alcohol dehydrogenase gene (int) is marked. The vector backbone is 1073 
not shown, drawings are not in scale. 1074 
 1075 
Figure 3.  1076 
Comparison of template constructs in mammalian cells. (A) U2OS, Vero E6 and BHK-21 1077 
cells were all co-transfected with CMV-P1234 and one of CMV-Fluc-Gluc (CMV), CMV-1078 
HH-Fluc-Gluc (CMV HH), HSPolI-Fluc-Gluc (HSPolI), HSPolI-HH-Fluc-Gluc (HSPolI 1079 
HH), or CGPolI-Fluc-Gluc (CGPolI). Control cells were all co-transfected with CMV-1080 
P1234
GAA
 and the same template-expressing plasmids. Cells were lysed at 18 h post 1081 
transfection. Fluc (replication, left panel) and Gluc (transcription, right panel) activities 1082 
generated by the active replicase were normalized to controls. Each column represents an 1083 
average of three independent experiments; error bars represent standard deviation. * 1084 
designates p<0.05, ** designates p<0.01, *** designates p<0.001 and **** designates 1085 
p<0.0001, ns – not significant (Student’s unpaired t-test). (B) U2OS and BHK-21 cells were 1086 
all co-transfected with CMV-P1234 and one of CMV-Fluc-Gluc, CMV-HH-Fluc-Gluc, 1087 
HSPolI-HH-Fluc-Gluc, HSPolI-Fluc-Gluc or CGPolI-Fluc-Gluc; control cells were all co-1088 
transfected with CMV-P1234
GAA
 and the same template-expressing plasmids or were mock-1089 
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transfected. Samples were collected at 18 h post transfection. RNA was analyzed by northern 1090 
blotting using a probe corresponding to the Fluc reporter gene to detect negative strands 1091 
(lower panel) or probe complementary to Gluc reporter gene to detect positive strands (upper 1092 
panel). “Genomic RNA” designates the full-length template RNA; note that an RNA of same 1093 
size is also synthesized by cellular RNA polymerases I and II and is therefore at the cases of 1094 
some promoters also detectable at the presence of inactive replicases (GAA). “Subgenomic 1095 
RNA” designates RNA synthesized by CHIKV replicase using the SG promoter. The 1096 
experiment was repeated two times with similar results; data from one experiment is shown. 1097 
 1098 
Figure 4.  1099 
Comparison of template constructs in mosquito cells. (A) C6/36 and AF319 cells were all 1100 
co-transfected with Ubi-P1234 and one of Ubi-Fluc-Gluc (Ubi), AegPolI-Fluc-Gluc 1101 
(AegPolI), AegPolI-HH-Fluc-Gluc (AegPolI HH) or AlbPolI-Fluc-Gluc (AlbPolI). Control 1102 
cells were all co-transfected with Ubi-P1234
GAA
 and the same template-expressing plasmids. 1103 
Cells were lysed at 48 h post transfection. Fluc (replication, left panel) and Gluc 1104 
(transcription, right panel) activities generated by the active replicase were normalized to 1105 
controls. Each column represents an average of three independent experiments; error bars 1106 
represent standard deviation. * designates p<0.05, ** designates p<0.01, ns – not significant 1107 
(Student’s unpaired t-test). (B) C6/36 and AF319 cells were all co-transfected with Ubi-1108 
P1234 and one of Ubi-Fluc-Gluc, AlbPolI-Fluc-Gluc, AegPolI-Fluc-Gluc or AegPolI-HH-1109 
Fluc-Gluc; control cells were all co-transfected with Ubi-P1234
GAA
 and the same template-1110 
expressing plasmids or were mock-transfected. Samples were collected at 48 h post 1111 
transfection. Positive-strand RNAs were revealed and the data is presented as described for 1112 
Fig. 3B except that 5-fold more total RNA and longer exposure were used to obtain the 1113 
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image. The experiment was repeated two times with similar results; data from one experiment 1114 
is shown. 1115 
Figure 5.  1116 
CHIKV infection triggers replication and transcription of template RNAs produced 1117 
from CMV-Fluc-Gluc, HSPolI-Fluc-Gluc, Ubi-Fluc-Gluc and AlbPolI-Fluc-Gluc 1118 
plasmids. (A) U2OS cells were transfected with  CMV-Fluc-Gluc or HSPolI-Fluc-Gluc 1119 
plasmids. At 18 h post transfection cells were either infected with CHIKV at an MOI 10 or 1120 
mock-infected. Cells were collected at 24 h p.i., lysed and Fluc (replication, left panel) and 1121 
Gluc (transcription, right panel) activities measured and normalized to the number of 1122 
transfected cells. (B) C6/36 cells were transfected with Ubi-Fluc-Gluc or AlbPolI-Fluc-Gluc 1123 
plasmids. At 36 h post transfection cells were either infected with CHIKV at an MOI 10 or 1124 
mock-infected. Cells were collected at 72 h p.i., lysed and Gluc activities measured and 1125 
normalized to the number of transfected cells. Each column represents an average of at least 1126 
three independent experiments; error bars represent standard deviation. **** designates 1127 
p<0.0001 (Student’s unpaired t-test). 1128 
 1129 
Figure 6.  1130 
Re-evaluation of activities of replicase mutants possessing no or strongly reduced RNA 1131 
synthesis abilities. U2OS cells were all co-transfected with HSPolI-Fluc-Gluc and one of 1132 
CMV-P
E
1234, CMV-P1
E
234-A, CMV-P1
E
234-B, CMV-P1
E
234-C, CMV-P1
E
234-D, CMV-1133 
P1234
E
, CMV-P1
DA
234, CMV-P1
WA
234, CMV-P12
EK
34, CMV-P12
EKPG
34, CMV-P12
KN
34, 1134 
CMV-P12
CA
34, CMV-P12
WA
34 or CMV-P12
CA+SA
34. Control cells were co-transfected with 1135 
HSPolI-Fluc-Gluc and CMV-P1234 or CMV-P1234
GAA
. Cells were lysed at 18 h post 1136 
transfection. (A) Fluc (replication) and (B) Gluc (transcription) activities generated by the 1137 
active replicase were normalized to controls. Each column represents an average of three 1138 
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independent experiments; error bars represent standard deviation. Names of mutant 1139 
polyproteins expressed by replicase expression plasmids are indicated below the graphs. With 1140 
exceptions of these marked „ns“ (not significant) all other mutants showed activity 1141 
significantly higher compared to negative control (P1234
GAA
) (Student’s unpaired t-test). 1142 
 1143 
Figure 7.  1144 
Effects of mutations in nsP1 of CHIKV for infectious virus rescue and trans-replicase 1145 
activities in mammalian and mosquito cells. (A) BHK-21 cells were transfected with one of 1146 
the following plasmids: CMV-ICRES1, CMV-ICRES1
DA
, CMV-ICRES1
YA
, CMV-ICRES1
RE
 1147 
or CMV-ICRES1
3C3A
. Left: results of ICA. Right: western blot of lysates from transfected 1148 
cells collected at 24 h p.t. CHIKV capsid protein was revealed by corresponding rabbit 1149 
polyclonal antiserum; β-actin was used as loading control. Data from one reproducible 1150 
experiment out of two independent expreiments is shown. (B) U2OS cells were all co-1151 
transfected with HSPolI-Fluc-Gluc and one of CMV-P1234, CMV-P1
DA
234, CMV-P1
YA
234, 1152 
CMV-P1
RE
234, CMV-P1
WA
234, CMV-P1
3C3A
234 or CMV-P1234
GAA
. Samples were 1153 
collected at 18 h post transfection. Production of positive-strand RNAs was estimated 1154 
measuring activities of Fluc (left panel) and Gluc (right panel) as described in Fig 3A. Each 1155 
column represents an average of three independent experiments; error bars represent standard 1156 
deviation. Viral protein expression was verified by western blotting using anti-nsP1 1157 
antiserum. (C) AF319 cells were all co-transfected with AegPolI-Fluc-Gluc and one of Ubi-1158 
P1234, Ubi-P1
DA
234, Ubi-P1
YA
234, Ubi-P1
RE
234, Ubi-P1
WA
234, Ubi-P1
3C3A
234 or Ubi-1159 
P1234
GAA
. Samples were collected at 48 h post transfection. Production of positive-strand 1160 
RNAs was estimated measuring activities of Fluc (left panel) and Gluc (right panel) as 1161 
described in Fig 3A. Each column represents an average of three independent experiments; 1162 
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error bars represent standard deviation. Viral protein expression was verified by western 1163 
blotting as described in panel B. 1164 
 1165 
 1166 
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  Table 1. Sequences of promoter – CHIKV 5’ UTR junctions for plasmids expressing template RNAs 
Plasmid Promoter 
residues  
-10 to -1 
Downstream part of promoter Leader +HH RZ (bold) CHIKV 
residues 1-10 
CMV-Fluc-
Gluc 
AGTGAACCGT - - ATGGCTGCGT
CMV-HH-
Fluc-Gluc 
AGTGAACCGT - GTATTTTTACAACAATTACCAACAACAACAAACAACAAACAACATTAC 
AATTACTATTTACAATTACAATGGCATACACACAGACAGCTACCACAT 
CAGCTTTGCTGGACACTGTCCGAGGAAACAACTCCTTGGTCTAATAAT 
AAAGCCATCTGATGAGAGCGAAAGCTCGAAACTGGAGGAAACTCCAGTC
ATGGCTGCGT
HSPolI-HH-
Fluc-Gluc 
CCGGGTTATT GCTGACACGCTGTCCTCTGG AGCCATCTGATGAGAGCGAAAGCTCGAAACTGGAGGAAACTCCAGTC ATGGCTGCGT
HSPolI-
Fluc-Gluc 
CCGGGTTATT - - ATGGCTGCGT
CGPolI-
Fluc-Gluc 
TGACACGCTT - - ATGGCTGCGT
Ubi-Fluc-
Gluc 
AAACCAGCTC - - ATGGCTGCGT
AegPolI-
HH-Fluc-
Gluc 
AAAACCCTTC AGGGAGGAAGGCAGTGT 
GCGTGGACCGGCAGGAA 
AATGTTCCGAAAGCAA 
AGCCATCTGATGAGAGCGAAAGCTCGAAACTGGAGGAAACTCCAGTC ATGGCTGCGT
AegPolI-
Fluc-Gluc 
AAAACCCTTC - - ATGGCTGCGT
AlbPolI-
Fluc-Gluc 
AAAACCCTAT - - ATGGCTGCGT
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